HI
INSY

HBK Investments’s Insys Therapeutics, Inc. INSY Stock Holding History

HBK Investments’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-21,837
Closed -$257K – 951
2016
Q3 		$257K Buy
+21,837
New +$332K ﹤0.01% 750
2014
Q2 		– Sell
-64,624
Closed -$1.34M – 1095
2014
Q1 		$1.34M Buy
+64,624
New +$1.28M 0.02% 404

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments's INSY Position: Q4 2016 in Review

HBK Investments sold out of Insys Therapeutics, Inc. (INSY) in Q4 2016, closing a stake of 21,837 shares — an estimated $257K sold.

HBK Investments first reported a position in INSY in Q1 2014 and held it in 2 quarters. The position peaked at $1.34M in Q1 2014. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • HBK Investments reported no remaining Insys Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • HBK Investments sold 21,837 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $257K.
  • HBK Investments first reported a position in Insys Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • HBK Investments's Insys Therapeutics, Inc. position peaked at $1.34M in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on HBK Investments's 13F filing for Q4 2016, filed 14 Feb 2017.